EpimAb Biotherapeutics Inc is a clinical stage biopharmaceutical company specializing in the development of multispecific antibodies, particularly bispecific antibodies, utilizing proprietary platforms to advance a pipeline of transformative assets for cancer treatment
EpimAb Biotherapeutics Inc is a clinical stage biopharmaceutical company specializing in the development of multispecific antibodies, particularly bispecific antibodies, utilizing proprietary platforms to advance a pipeline of transformative assets for cancer treatment.